1. Home
  2. MUC vs NBTX Comparison

MUC vs NBTX Comparison

Compare MUC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings California Quality Fund Inc.

MUC

Blackrock MuniHoldings California Quality Fund Inc.

HOLD

Current Price

$10.72

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$32.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUC
NBTX
Founded
N/A
2003
Country
United States
France
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
MUC
NBTX
Price
$10.72
$32.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$26.00
AVG Volume (30 Days)
243.5K
42.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$11.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.97
$2.99
52 Week High
$11.04
$41.89

Technical Indicators

Market Signals
Indicator
MUC
NBTX
Relative Strength Index (RSI) 38.37 55.28
Support Level $10.71 $20.11
Resistance Level $10.78 $41.89
Average True Range (ATR) 0.09 2.83
MACD -0.02 -0.37
Stochastic Oscillator 8.57 32.97

Price Performance

Historical Comparison
MUC
NBTX

About MUC Blackrock MuniHoldings California Quality Fund Inc.

BlackRock MuniHoldings California Quality Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes and California personal income taxes. The fund mainly invests in municipal obligations exempt from U.S. federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and California personal income taxes. Under normal market conditions, it invests a majority of its managed assets in investment-grade municipal obligations with remaining maturities of one year or more at the time of investment. It can also invest in below investment-grade securities, or directly in such securities or synthetically through the use of derivatives.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: